HempMeds Brasil, a subsidiary of Medical Marijuana, Inc., just revealed that April 2021 was the company’s biggest revenue month ever.
Dr. Stuart Titus, CEO of Medical Marijuana, Inc., remarked, “Our HempMeds Brasil operations have witnessed a constant growth throughout the years.
Our idea is to approach as many needy consumers as possible, and last month’s accomplishments show that we are still expanding our reach to our target audiences.”
The firm did not provide specific sales statistics. Still, it did say that in reaction to April’s sales, it will be scaling its Brazil operations to meet demand, modernizing its consumer-facing website, and expanding the size of its Brazil facilities.
“We want to work with Brazil’s leading higher education institution to educate medical professionals on the potential advantages of cannabidiol (CBD) in the coming months to support our sustained growth, and we are pushing forward in establishing relationships with well-respected professional and Olympic athletes,” stated HempMeds® Brasil Managing Director Matheus Patelli. “My team has been able to successfully demonstrate to Brazilian residents that our goods are of the greatest quality and are trustworthy, just like the individuals who work for the Company.”
